Sexual Wellness Peptide therapies designed to support hormonal signaling, libido, reproductive wellness, and overall vitality
To qualify, you must be 18, have Medicare Part D (prescription drug coverage) and meet the programs clinical criteria: A BMI of 35 or higher A BMI of 30 or higher and one or more of the following conditions: a diagnosis of heart failure with preserved ejection fraction, uncontrolled hypertension while on at least two blood pressure medications, or chronic kidney disease stage 3a or above A BMI of 27 or higher and one or more of the following conditions a diagnosis of pre-diabetes, a previous heart attack or stroke, or symptomatic peripheral artery disease Those with type 2 diabetes, moderate to severe obstructive sleep apnea, or MASH (fatty liver disease) are ineligible for the Medicare GLP-1 Bridge program
These tissues have inherently poor vascularity, which limits healing capacity
Zepbound / Mounjaro titrates from 2.5 mg up to 15 mg over 20 weeks
Helps with Side Effects GLP-1 agonists are known to cause side effects like nausea, vomiting, and diarrhea, particularly in the early stages of treatment
Because GLP-1 medications improve metabolic health, researchers are exploring whether they might also help reduce processes linked to neurodegeneration including inflammation in the brain, insulin resistance, and damage to brain cells